Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 511 to 525 of 1205 results for pain

  1. Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (HTG549)

    Evidence-based recommendations on electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease. This involves delivering electrical impulses to weakened muscles using electrodes placed on the skin.

    HealthTech guidance
    Published
    5 August 2020
    View recommendations

    Sections for HTG549

  2. Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea (HTG672)

    Evidence-based recommendations on daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea. This involves placing a mouthpiece around the tongue inside the mouth (intraoral). It delivers electrical stimulation to the muscles of the tongue (neuromuscular). The aim is to reduce airway obstruction during sleep.

    HealthTech guidance
    Published
    19 April 2023
    View recommendations

    Sections for HTG672

  3. Temporary dressings for up to 72 hours between wound excision and definitive soft tissue cover: What is the most clinically and cost effective temporary (up to 72 hours) dressing (including negative pressure dressings) for open fractures after wound excision for: - minimising the number of dressing changes or supplementary dressings - minimising the number of associated bedding changes - acceptability for patients, for example, in terms of minimising pain - minimising nursing time.

    changes - acceptability for patients, for example, in terms of minimising pain - minimising nursing time. Any explanatory notes(if...

    Research recommendation
    Published
    12 December 2022

  4. NICE encourages further research comparing autologous blood injections (with or without techniques to produce platelet-rich plasma) against established nonsurgical methods for managing tendinopathy. Trials should clearly describe patient selection (including the site of tendinopathy, duration of symptoms and any prior treatments) and document whether a 'dry needling' technique is used. Outcomes should include specific measures of pain, quality of life and function, and whether subsequent surgical intervention is needed.

    needling' technique is used. Outcomes should include specific measures of pain, quality of life and function, and whether subsequent...

    Research recommendation
    Published
    9 June 2015

  5. Autism spectrum disorder in adults: diagnosis and management (CG142)

    This guideline covers diagnosing and managing suspected or confirmed autism spectrum disorder (autism, Asperger’s syndrome and atypical autism) in people aged 18 and over. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism.

    Clinical guideline
    Last updated
    14 June 2021
    View recommendations

    Sections for CG142

  6. Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over (TA1051)

    Evidence-based recommendations on efanesoctocog alfa (Altuvoct) for treating and preventing bleeding episodes in haemophilia A in people 2 years and over.

    Technology appraisal guidance
    Published
    2 April 2025
    View recommendations

    Sections for TA1051

  7. Patisiran for treating hereditary transthyretin amyloidosis (HST10)

    Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy.

    Highly specialised technologies guidance
    Published
    14 August 2019
    View recommendations

    Sections for HST10

  8. Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (HTG646)

    Evidence-based recommendations on percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules. This involves using microwaves from a wire inserted into the nodule to heat and destroy it (ablation).

    HealthTech guidance
    Published
    16 November 2022
    View recommendations

    Sections for HTG646

  9. Endoscopic submucosal dissection of gastric lesions (HTG233)

    Evidence-based recommendations on endoscopic submucosal dissection (ESD) of gastric lesions. This involves inserting a thin telescope through the mouth into the stomach to view the area and removing the lesion with special equipment.

    HealthTech guidance
    Published
    27 October 2010
    View recommendations

    Sections for HTG233

  10. Selective peripheral denervation for cervical dystonia (HTG51)

    Evidence-based recommendations on selective peripheral denervation for cervical dystonia. This involves cutting the nerves to the muscles of the neck through a large skin incision.

    HealthTech guidance
    Published
    25 August 2004
    View recommendations

    Sections for HTG51

  11. Laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina (HTG464)

    Evidence-based recommendations on laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina. This involves inserting mesh to hold the uterus or the top of the vagina in place.

    HealthTech guidance
    Published
    14 March 2018
    View recommendations

    Sections for HTG464

  12. Further research into joint distraction for ankle osteoarthritis should include comparative studies against the natural history of the disease and against other forms of management. Studies should record patient selection, pain relief, functional outcomes, complications, and quality of life in the long term. They should also report the nature and timing of any further surgery on the ankle.Minimising loss to follow-up is of particular importance. NICE may update the guidance on publication of further evidence.

    against other forms of management. Studies should record patient selection, pain relief, functional outcomes, complications, and quality...

    Research recommendation
    Published
    25 January 2016

  13. Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds (MIB11)

    NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds

    Medtech innovation briefing
    Published
    19 November 2014

  14. Linzagolix for treating moderate to severe symptoms of uterine fibroids (TA996)

    Evidence-based recommendations on linzagolix (Yselty) for treating moderate to severe symptoms of fibroids in adults of reproductive age.

    Technology appraisal guidance
    Published
    14 August 2024
    View recommendations

    Sections for TA996

  15. Fallopian tube recanalisation by guidewire (HTG44)

    Evidence-based recommendations on fallopian tube recanalisation by guidewire. This involves injecting dye through a narrow tube inserted into the fallopian tube and if this does not unblock it, using a guidewire.

    HealthTech guidance
    Published
    28 July 2004
    View recommendations

    Sections for HTG44